News
Current position:Product Center > Antibodies > Biosimilar Antibodies > Anti-CD20 hIgG1 Reference Antibody (Ocrebio)
Anti-CD20 hIgG1 Reference Antibody (Ocrebio)
Product Info
Get A Quote

Cat. No.:GM-87986MAB

Product:Anti-CD20 hIgG1 Reference Antibody (Ocrebio)


Cat. No. & Size
Get A Quote

GM-87986MAB-1mg / 1 mg

GM-87986MAB-5mg / 5 mg

GM-87986MAB-25mg / 5 mg * 5 vials

GM-87986MAB-50mg / 50 mg

GM-87986MAB-100mg / 50 mg * 2 vials

Description
Get A Quote

Expression System     CHO

Aggregation             < 5% as determined by SEC-HPLC

Purity                           > 95% as determined by SDS-PAGE

Endotoxin                    < 1 EU/mg, determined by LAL gel clotting assay

Sterility                        0.2 μm Filtered

Target                          CD20

Clone                              Ocrelizumab

Alternative Names         B1, Bp35, MS4A1, CVID5, FMC7, LEU-16, S7

Source/Isotype           Monoclonal human IgG1(KEEM), Kappa

Application                      /

Description                 The CD20 gene encodes a transmembrane protein called CD20 (MS4A1), which is specifically expressed on the surface of B cells. Ocrelizumab is a humanized anti-CD20 monoclonal antibody that primarily induces B-cell lysis or apoptosis through two mechanisms: antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC).

Formulation                phosphate-buffered solution, pH 7.2-7.4.


Data
Get A Quote

image.png

image.png

Message Consultation
If you have more questions, please fill in the relevant information,we'll respond as soon as possible to assist you!
Reset
Submit
You can also contact us on the Scientist and Science Exchange marketplaces.
Current position:Product Center > -- > Anti-CD20 hIgG1 Reference Antibody (Ocrebio)
classify
Anti-CD20 hIgG1 Reference Antibody (Ocrebio)
Product Info
Get A Quote

Cat. No.:GM-87986MAB

Product:Anti-CD20 hIgG1 Reference Antibody (Ocrebio)


Cat. No. & Size
Get A Quote

GM-87986MAB-1mg / 1 mg

GM-87986MAB-5mg / 5 mg

GM-87986MAB-25mg / 5 mg * 5 vials

GM-87986MAB-50mg / 50 mg

GM-87986MAB-100mg / 50 mg * 2 vials

Description
Get A Quote

Expression System     CHO

Aggregation             < 5% as determined by SEC-HPLC

Purity                           > 95% as determined by SDS-PAGE

Endotoxin                    < 1 EU/mg, determined by LAL gel clotting assay

Sterility                        0.2 μm Filtered

Target                          CD20

Clone                              Ocrelizumab

Alternative Names         B1, Bp35, MS4A1, CVID5, FMC7, LEU-16, S7

Source/Isotype           Monoclonal human IgG1(KEEM), Kappa

Application                      /

Description                 The CD20 gene encodes a transmembrane protein called CD20 (MS4A1), which is specifically expressed on the surface of B cells. Ocrelizumab is a humanized anti-CD20 monoclonal antibody that primarily induces B-cell lysis or apoptosis through two mechanisms: antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC).

Formulation                phosphate-buffered solution, pH 7.2-7.4.


Data
Get A Quote

image.png

image.png

Message Consultation
If you have more questions, please fill in the relevant information,we'll respond as soon as possible to assist you!
Reset
Submit
You can also contact us on the Scientist and Science Exchange marketplaces.
Message consultation
reset
submit
Service
Message
Message consultation
reset
submit